ABSTRACT: This paper describes select results of a longitudinal study of 62 mild to moderate Alzheimer's disease (AD) patients, in comparison to 60 age-matched healthy controls. Initial neurologic, radiologic, psychiatric, laboratory and cognitive examinations, required two full days, followed by one-day examinations at annual intervals. Of the total original sample, 31 AD patients and 39 controls could actually be followed for three annual examinations. Cognitive examination data confirmed cross-sectional (group discriminative) validity of memory and language measures, and showed the expected longitudinal deterioration in the AD sample, with controls maintaining consistent performance over the three years. However, those measures showing largest group differences at initial examination were not the best for tracking patient deterioration over time. Implications of these results for the selection of cognitive assessment measures are discussed. RESUME: Evaluation cognitive dans la maladie d'Alzheimer: perspective transversale et longitudinale. Cet article decrit des resultats s61ectionnes a partir d'une etude longitudinale de 62 cas de maladie d'Alzheimer (MA) de discrete a mod6ree, compares a 60 temoins sains apparies pour l'age. Une evaluation initiate d'une duree de deux jours comprenant des examens neurologiques, radiologiques, psychiatriques, cognitifs et de laboratoire etait suivie par un examen annuel d'une dur6e d'une journ6e. Sur l'6chantillon initial, 31 patients souffrant de MA et 39 tdmoins ont pu etre suivis sur une periode de trois ans. Les r6sultats de l'examen cognitif ont confirme la validite transversale (discriminant pour le groupe) des mesures de la memoire et du langage et ont montre la deterioration longitudinale previsible dans l'echantillon souffrant de MA, alors que les temoins ont maintenu leur performance pendant cette periode de 3 ans. Cependant, les mesures qui demontrent la plus grande difference entre les groupes au moment de l'examen initial n'6taient pas les meilleures pour suivre 1'evolution de la deterioration. Nous discutons des implications de ces r£sultats pour la selection de mesures devaluation cognitive. _ , " , " . 1 / l n , . , . -" . _ , Can. J. Neurol. Set. 1986; 13:420-423 Within recent years, considerable attention has focused upon the validation of cognitive measures appropriate for the assessment of dementia, particularly Alzheimer's disease (AD). Given the prominence of memory impairment and decreased verbal fluency in the clinical presentation of AD, 4 it is not surprising that memory and language assessment have frequently been the focus of test validation research. Studies comparing mildly demented AD patients to healthy controls have found psychometric measures of memory (e.g., the Wechsler Memory Scale 5 ) and of verbal fluency (e.g., generating as many words as possible that start with a given letter or belong to a given category) to be highly discriminating. Thus, available cross-sectional data provides evidence for the discriminative validity of particular memory and verbal fluency measures, in applications where differentiation of mild AD patients from healthy older persons is desired. However, there remains a relative lack of published data concerning the longitudinal validity of these same measures. Memory and verbal fluency assessment instruments have been shown to be predictive of differences, among AD patients, in overall rate of dementia progression over a one-year interval, l0 but it is not yet clear whether these measures will validly track the expected longitudinal deterioration of cognition in AD. It cannot be assumed that measures able to differentiate mild AD patients from healthy older persons will also show longitudinal validity, since instruments sufficiently sensitive to mild dementia may show a truncation of variance ("basement effects"), as dementia severity increases over time.
Within recent years, considerable attention has focused upon the validation of cognitive measures appropriate for the assessment of dementia, particularly Alzheimer's disease (AD). Given the prominence of memory impairment and decreased verbal fluency in the clinical presentation of AD, 4 it is not surprising that memory and language assessment have frequently been the focus of test validation research. Studies comparing mildly demented AD patients to healthy controls have found psychometric measures of memory (e.g., the Wechsler Memory Scale 5 ) and of verbal fluency (e.g., generating as many words as possible that start with a given letter or belong to a given category) to be highly discriminating. Thus, available cross-sectional data provides evidence for the discriminative validity of particular memory and verbal fluency measures, in applications where differentiation of mild AD patients from healthy older persons is desired. However, there remains a relative lack of published data concerning the longitudinal validity of these same measures. Memory and verbal fluency assessment instruments have been shown to be predictive of differences, among AD patients, in overall rate of dementia progression over a one-year interval, l0 but it is not yet clear whether these measures will validly track the expected longitudinal deterioration of cognition in AD. It cannot be assumed that measures able to differentiate mild AD patients from healthy older persons will also show longitudinal validity, since instruments sufficiently sensitive to mild dementia may show a truncation of variance ("basement effects"), as dementia severity increases over time.
Questions concerning longitudinal validity are of considerable importance for neuropsychological research in dementia. An instrument with good initial discriminative validity, but variance truncation as dementia severity progresses, might not be the best choice for studies concerned with neurobiological correlates of cognitive deficit in AD. This is because such truncation in measure variance will limit the magnitude of any relationship which can be observed between a given neurobio-LE JOURNAL CANADIEN DES SCIENCES NEUROLOGIQUES logic (e.g., anatomic, physiologic, chemical) variable and the cognitive measure in question." The purpose of the present study is to examine both the discriminative (cross-sectional) and longitudinal validity of select memory, verbal fluency, and other language measures, in samples of AD patients and agematched healthy controls.
METHODS AND MATERIALS

Subjects
The initial sample consisted of 62 AD patients and 60 healthy controls. The AD patients were referred to the study by cooperating neurologists and internists, while controls were volunteers from the community who were paid for their project participation. All subjects received comprehensive evaluations, including physical and neurologic examination, a computerized tomographic (CT) scan, electroencephalogram (EEG), psychiatric interview, interview with a close family member, and extensive cognitive assessment. The AD patients met DSM-III 12 criteria for Primary Degenerative Dementia. A series of laboratory procedures (including blood counts, red blood cell indices, erythrocyte sedimentation rate, blood urea nitrogen, vitamin B l2 levels, folic acid levels, urinalysis, electrolytes, sugar, calcium, phosphorus, liver function, T 4 , serum protein electrophoresis, electrocardiogram, and chest and skull radiograms) were performed in order to rule out various infectious, toxic or metabolic disorders. The Hachinski ischemic scale 13 was used to assist in eliminating from the sample any patients suspect of multi-infarct dementia. The present sample of patients meets recently established criteria 14 for clinical diagnosis of probable Alzheimer's disease. No patients were institutionalized at the time of entry into the sample, and all patients had either mild or early moderate dementia severity, by current criteria. 15, 16 The initial examinations required two full days, followed by one day examinations at annual intervals. The total duration of the study was five years, with new subjects entering during years one through four. Eight patients and 14 controls entered in year four, and therefore had only two annual examinations. This reduced the potential sample which could be followed for three years to 54 patients and 46 controls. Of these, 31 patients and 39 controls were actually followed for at least three annual examinations. Five controls (11 percent) were lost to follow-up, with two deaths, one medical complication (stroke) and two refusals. An additional two controls, although followed, were not included in analyses, as neurological examination raised the possibility of minor focal neurologic abnormality at reexamination. Twenty-three patients (43 percent) were lost to follow-up, with five deaths, four medical complications, five moves out of state, and nine refusals. Demographic data for subjects followed for three years, and those lost to follow-up is shown in Table I . The 70 subjects who were followed for three years did not significantly differ from the original sample of 122 in age, sex, education, physical and neurologic examination results, medical history, or initial dementia severity. However, AD patients lost to follow-up had a slightly longer dementia history, as estimated by a close family member, than patients who remained in the sample for three annual examinations. AD versus control subjects followed for three years were not significantly different in age, sex or education.
Cognitive Measures
All subjects were administered a large battery of memory, language, perceptual and emotional assessment instruments, the published cross-sectional results of which have been reviewed elsewhere. 2 For purposes of the present report, a subset of measures of memory, verbal fluency, and naming were selected to be consistent with those reported to have discriminative (mild AD versus healthy control) validity in previously published research. 6 
"
9 These include the Logical Memory and Visual Reproduction subtests of the Wechsler Memory Scale (WMS), 5 and the Animal Naming, Visual Confrontation Naming, and Spoken Commands subtests of the Boston Diagnostic Aphasia Examination (BDAE).' 7 Both the Wechsler Memory Scale and the Boston Diagnostic Aphasia Examination subtests have normative data available for adults through 80 and 85 years of age, respectively, 1819 facilitating their clinical utility. The Logical Memory subtest of the WMS requires the subject to immediately recall each of two brief paragraphs spoken by the examiner, while the WMS Visual Reproduction Subtest involves the presentation, for ten seconds each, of three different non-representational geometric forms, which are then to be immediately drawn from memory. The BDAE Animal Naming subtest asks the subject to verbally generate as many names of animals as possible within a 60 second time period. The BDAE Visual Confrontation Naming subtest involves the examiner pointing to each of several line drawings which must be named by the subject. Finally, the BDAE Spoken Commands subtest requires the subject to execute simple commands spoken by the examiner. All subtests were individually administered to patients and controls, in a quiet and private examination room, by graduate research assistants experienced in maintaining the cooperation of dementia patients.
Followed
Lost In order to determine initial group differences on the memory, verbal fluency, and other language measures, as well as any possible differences between subjects in each group who were followed for three years versus those who were not, a series of two-way (group by stay-in/drop-out status) analyses of variance (ANOVA) were computed. Significant group main effects (p<.000l) were obtained on all dependent variables, confirming the discriminant (diagnostic) validity of the measures selected. No significant main effects of followed versus lost to follow-up, nor significant group by follow-up interaction effects were obtained. Given the absence of follow-up status (followed versus not followed) main effects and group by follow-up interactions, it can be concluded that the sample available for each of the three annual reexaminations is representative, in terms of initial memory and language functioning, of the entire sample originally enrolled into the study.
While the group main effects were highly significant for all dependent variables, these variables did differ in the degree to which they differentiated the groups (discriminative efficiency). Longitudinal data analyses, while also confirming the longitudinal validity of each of the subtests, indicate a quite different ordering, in terms of their ability to track progression of dementia severity. Analyses of longitudinal data are based upon a smaller group of 22 AD patients and 39 controls, since nine of the AD patients were too demented at either the second or third examination for meaningful collection of all subtest data. Group means and standard deviations for the AD and control groups, across the three annual evaluations, are shown in Table 2 .
Multivariate analyses of variance (MANOVA) were performed for each of the subtests, using a group (AD versus control) by repeated measures (each of the three annual examinations) design. As would be expected from the cross-sectional analyses described above, group main effects were highly significant (p<.0001) for all subtests. As can be seen in Table two , control subjects showed consistent subtest performance across the three annual examinations, while AD patients showed progressive deterioration (confirmed by significant (p< .05) interaction term multivariate F ratios).
The magnitude of the interaction effect (group by annual evaluation) multivariate F ratio can be employed as an index of a subtest's ability to tract longitudinal deterioration in the AD patients (the greater the change, over repeated examinations, in the AD group, relative to controls, the larger the interaction effect). Using this index, the subtests demonstrated the following rank ordering in ability to track AD longitudinal deterioration: (1) BDAE Spoken Commands (interaction multivariate F= 18.75),(2) BDAE Visual Confrontation Naming (interaction multivariate F= 13.91), (3) WMS Visual Reproduction (interaction multivariate F = 7.36), (4) BDAE Animal Naming (interaction multivariate F = 6.74), (5) WMS Logical Memory (interaction multivariate F = 4.31). This ordering, with the minor exception of the interchanged positions of WMS Visual Repro- Table 2 , this appears due to a systematic reduction in variability over time, for those subtests most sensitive to initial group difference.
DISCUSSION
As expected, based upon results of previous research, 6 " 9 the presently employed measures of verbal (WMS Logical Memory) and nonverbal (WMS Visual Reproduction) recent memory, as well as measures of verbal fluency (BDAE Animal Naming), object naming (BDAE Visual Confrontation Naming), and auditory comprehension (BDAE Spoken Commands) all show validity in documenting differences between mild to moderate AD and age-matched healthy controls. Further, consistent with clinical impressions and previous research, 6,7 memory and verbal fluency measures provide more efficient group discrimination than object naming or auditory comprehension measures, and therefore appear to be good choices for application in initial diagnostic assessment.
All of the presently employed subtests also demonstrate validity in documenting the progressive deterioration of AD (as confirmed by significant group by repeated examination multivariate interaction effects). However, their relative efficiency in tracking AD patient deterioration is generally opposite their ordering of efficiency in initial group discrimination. This reversal of subtest efficiency, when comparing discriminative and longitudinal validity, appears attributable to the effects of variance truncation. That is, those measures most sensitive to initial differences between AD patients and controls (recent memory and verbal fluency measures) are also those which show "basement effects" (reduction in range of variability) over repeated yearly examinations, for the AD patients. It should be pointed out that these basement effects are even more marked than the present data might suggest, since those AD patients too demented at follow-up examinations to comprehend task instructions were eliminated from the longitudinal sample. As we have previously demonstrated, 20 AD patients who cannot be validly tested with a particular task, at follow-up evaluation, show more rapid dementia progression (as indicated by a simple mental status examination), than those patients who continue to be testable.
Thus, while immediate verbal and nonverbal memory and verbal fluency measures may be good choices for initial diagnostic assessment, 6 other measures, such as those of object naming and auditory comprehension, may provide better approaches to tracking the cognitive deterioration of AD, across a range of dementia severity (despite the fact that the latter measures are less efficient at initial group discrimination). Overall, these results argue for an approach to cognitive assessment in dementia which explicitly recognizes the deteriorative nature of dementing illness, and provides different instruments for the assessment of mild, early impairment, as well as for those more pervasive and severe deficits seen with dementia progression.
